Breaking News Instant updates and real-time market news.

PTGX

Protagonist Therapeutics

$9.72

2.7 (38.46%)

13:16
08/06/18
08/06
13:16
08/06/18
13:16

Protagonist Therapeutics' PTG-100 'back on track,' says Leerink

Leerink analyst Joseph Schwartz says PTG-100 in Ulcerative colitis is "back on track," increasing his confidence in Protagonist Therapeutics' peptide technology platform. The analyst notes that the company reported this morning an unexpected, but very positive, turnaround of its lead program, PTG-100, and will now pursue late-stage clinical development, assuming a positive discussion with the FDA occurs in 2H. While it is unfortunate that the program lost some time when the data set was initially mis-scored and deemed futile when in fact today's news suggests that PTG-100 could have robust clinical efficacy, Schwartz believes that Protagonist's persistence to uncover the truth leading to the resuscitation of the program is positive. The analyst reiterates an Outperform rating on the stock and raised his price target on the shares to $21 from $13.

  • 06

    Aug

PTGX Protagonist Therapeutics
$9.72

2.7 (38.46%)

03/26/18
STFL
03/26/18
DOWNGRADE
Target $11
STFL
Hold
Protagonist Therapeutics downgraded to Hold from Buy at Stifel
Stifel analyst Adam Walsh downgraded Protagonist Therapeutics to Hold and cut his price target for the shares to $11 from $32. The downgrade follows news that the company is discontinuing its Phase 2b study of PTG-100 in patients with moderate to severe ulcerative colitis.
03/27/18
BMOC
03/27/18
NO CHANGE
Target $13
BMOC
Outperform
Protagonist Therapeutics price target lowered to $13 from $42 at BMO Capital
BMO Capital analyst M. Ian Somaiya slashed his price target on Protagonist Therapeutics (PTGX) to $13 following the announcement that the company is discontinuing its Phase 2b study of PTG-100 in patients with moderate to severe ulcerative colitis. Somaiya adds that his valuation is now driven by the risk-adjusted sales model for PTG-200, which "represents a higher probability clinical program with peak sales of over $2B". The analyst also notes that he continues to exclude the clinical data of PTG-300 from his model. Despite the steep price target revision, Somaiya keeps his Outperform rating and recommends that investors buy into the weakness after the PTG-100 clinical disappointment on anticipated PTG-200 data and the advancement of Johnson&Johnson (JNJ) - shared Stelara.
06/06/18
LEHM
06/06/18
DOWNGRADE
Target $8.5
LEHM
Equal Weight
Protagonist downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Protagonist Therapeutics to Equal Weight and lowered his price target for the shares to $8.50 from $30. The analyst continues to see value in the company's pipeline assets, but does expect achievement of key catalysts until the second half of 2019. As such, the analyst sees greater near-term potential in small cap names with catalysts upcoming, such as Foamix (FOMX).
08/06/18
LEER
08/06/18
NO CHANGE
Target $21
LEER
Outperform
Protagonist price target raised to $21 after study re-analysis at Leerink
Leerink analyst Joseph P. Schwartz raised his price target on Protagonist Therapeutics shares to $21 from $13 after the company announced results from an independent blinded re-analysis of the Phase 2 PROPEL study of oral alpha-4-beta-7 integrin antagonist PTG-100 for the treatment of patients with ulcerative colitis. He maintains an Outperform rating on Protagonist shares.

TODAY'S FREE FLY STORIES

14:03
03/22/19
03/22
14:03
03/22/19
14:03
General news
Treasury Budget data reported »

February Treasury Budget…

QCOM

Qualcomm

$57.16

-0.6 (-1.04%)

14:00
03/22/19
03/22
14:00
03/22/19
14:00
Options
Size spread in Qualcomm as shares slip »

Size spread in Qualcomm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EVER

EverQuote

$7.80

-0.1 (-1.27%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
EverQuote management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

RYTM

Rhythm Pharmaceuticals

$30.01

-0.64 (-2.09%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
Rhythm Pharmaceuticals management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TWOU

2U

$66.19

-2.92 (-4.23%)

13:57
03/22/19
03/22
13:57
03/22/19
13:57
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

GLW

Corning

$33.89

-0.91 (-2.61%)

13:55
03/22/19
03/22
13:55
03/22/19
13:55
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEC

Alphatec

$2.60

-0.12 (-4.41%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Alphatec management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

TLRA

Telaria

$6.16

-0.25 (-3.90%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

SRDX

Surmodics

$42.26

-3.67 (-7.99%)

13:51
03/22/19
03/22
13:51
03/22/19
13:51
Conference/Events
Surmodics management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TPR

Tapestry

$31.23

-0.72 (-2.25%)

13:49
03/22/19
03/22
13:49
03/22/19
13:49
Options
Tapestry option volume 4x normal as shares test multiyear lows »

Tapestry option volume 4x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

, RHHBY

Roche

$0.00

(0.00%)

13:46
03/22/19
03/22
13:46
03/22/19
13:46
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary  »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

13:45
03/22/19
03/22
13:45
03/22/19
13:45
General news
Treasury Budget to be reported at 14:00 »

February Treasury Budget…

SLCA

U.S. Silica

$15.90

-1.08 (-6.36%)

13:40
03/22/19
03/22
13:40
03/22/19
13:40
Options
6.3% drop in Silica motivates an upside call buyer »

6.3% drop in Silica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

SHOP

Shopify

$201.50

-3.48 (-1.70%)

13:39
03/22/19
03/22
13:39
03/22/19
13:39
Hot Stocks
Mailchimp asks to remove Shopify integration over new terms of service »

Mailchimp issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$139.28

-2.09 (-1.48%)

13:35
03/22/19
03/22
13:35
03/22/19
13:35
Options
IBM put volume heavy and directionally bearish »

Bearish flow noted in IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

PLCE

Children's Place

$86.53

-0.97 (-1.11%)

13:22
03/22/19
03/22
13:22
03/22/19
13:22
Conference/Events
Children's Place management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 02

    Apr

SPLK

Splunk

$126.05

-6.43 (-4.85%)

13:20
03/22/19
03/22
13:20
03/22/19
13:20
Options
Odd opening print in Splunk expiring contracts »

Odd opening print in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 09

    Jul

VSAT

ViaSat

$75.82

-1.15 (-1.49%)

13:18
03/22/19
03/22
13:18
03/22/19
13:18
Conference/Events
ViaSat management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TDS

Telephone and Data

$31.39

-0.47 (-1.48%)

13:17
03/22/19
03/22
13:17
03/22/19
13:17
Conference/Events
Telephone and Data management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
03/22/19
03/22
13:17
03/22/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USM

U.S. Cellular

$46.51

-0.73 (-1.55%)

13:16
03/22/19
03/22
13:16
03/22/19
13:16
Conference/Events
U.S. Cellular management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
03/22/19
03/22
13:16
03/22/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$18.77

-0.33 (-1.73%)

13:16
03/22/19
03/22
13:16
03/22/19
13:16
Conference/Events
Global Net Lease management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

  • 15

    Apr

MMM

3M

$204.97

-4.62 (-2.20%)

13:15
03/22/19
03/22
13:15
03/22/19
13:15
Options
3M put volume heavy and directionally bearish »

Bearish flow noted in 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

PCTI

PCTEL

$5.21

-0.02 (-0.38%)

13:14
03/22/19
03/22
13:14
03/22/19
13:14
Conference/Events
PCTEL management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.